BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15173013)

  • 1. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens.
    Emmenegger U; Man S; Shaked Y; Francia G; Wong JW; Hicklin DJ; Kerbel RS
    Cancer Res; 2004 Jun; 64(11):3994-4000. PubMed ID: 15173013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
    Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
    Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy.
    Shaked Y; Emmenegger U; Francia G; Chen L; Lee CR; Man S; Paraghamian A; Ben-David Y; Kerbel RS
    Cancer Res; 2005 Aug; 65(16):7045-51. PubMed ID: 16103050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
    Hermans IF; Chong TW; Palmowski MJ; Harris AL; Cerundolo V
    Cancer Res; 2003 Dec; 63(23):8408-13. PubMed ID: 14679003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Park ST; Jang JW; Kim GD; Park JA; Hur W; Woo HY; Kim JD; Kwon JH; Yoo CR; Bae SH; Choi JY; Yoon SK
    Cancer Chemother Pharmacol; 2010 May; 65(6):1029-37. PubMed ID: 19701751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia.
    Emmenegger U; Morton GC; Francia G; Shaked Y; Franco M; Weinerman A; Man S; Kerbel RS
    Cancer Res; 2006 Feb; 66(3):1664-74. PubMed ID: 16452226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose metronomic delivery of cyclophosphamide is less detrimental to granulosa cell viability, ovarian function, and fertility than maximum tolerated dose delivery in the mouse.
    Dynes J; Osz K; Hooper A; Petrik J
    Biol Reprod; 2017 Sep; 97(3):449-465. PubMed ID: 29024988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.
    Bertolini F; Paul S; Mancuso P; Monestiroli S; Gobbi A; Shaked Y; Kerbel RS
    Cancer Res; 2003 Aug; 63(15):4342-6. PubMed ID: 12907602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
    Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS
    Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
    Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiangiogenic effect of continuous low-dose chemotherapy on Lewis lung carcinoma].
    Kang X; Zhang Q; Tong D; Zhao W
    Zhongguo Fei Ai Za Zhi; 2005 Jun; 8(3):181-5. PubMed ID: 21190615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts.
    Zhang M; Tao W; Pan S; Sun X; Jiang H
    Anticancer Drugs; 2009 Jun; 20(5):355-63. PubMed ID: 19318912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice.
    Jiang H; Tao W; Zhang M; Pan S; Kanwar JR; Sun X
    Cancer Invest; 2010 Jan; 28(1):74-84. PubMed ID: 20001297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.
    Buckstein R; Kerbel RS; Shaked Y; Nayar R; Foden C; Turner R; Lee CR; Taylor D; Zhang L; Man S; Baruchel S; Stempak D; Bertolini F; Crump M
    Clin Cancer Res; 2006 Sep; 12(17):5190-8. PubMed ID: 16951238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes and significance of peripheral blood platelet count in tumor shrinkage induced by a low dose of CTX in T739 mice].
    Li ML; Jia YJ; Jiang MN; Shu XH; Li CG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):567-9. PubMed ID: 18538085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumors that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide.
    Emmenegger U; Francia G; Chow A; Shaked Y; Kouri A; Man S; Kerbel RS
    Neoplasia; 2011 Jan; 13(1):40-8. PubMed ID: 21245939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A.
    Albertsson P; Lennernäs B; Norrby K
    Acta Oncol; 2006; 45(2):144-55. PubMed ID: 16546859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model.
    Jia LJ; Wei DP; Sun QM; Jin GH; Li SF; Huang Y; Hua ZC
    Int J Cancer; 2007 Aug; 121(3):666-74. PubMed ID: 17397027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study.
    Lord R; Nair S; Schache A; Spicer J; Somaihah N; Khoo V; Pandha H
    J Urol; 2007 Jun; 177(6):2136-40; discussion 2140. PubMed ID: 17509300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.